See more : Mako Mining Corp. (MAKOF) Income Statement Analysis – Financial Results
Complete financial analysis of Ladprao General Hospital Public Company Limited (LPH.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ladprao General Hospital Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Big Sky Growth Partners, Inc. (BSKYW) Income Statement Analysis – Financial Results
- Progyny, Inc. (PGNY) Income Statement Analysis – Financial Results
- CHP Merger Corp. (CHPMU) Income Statement Analysis – Financial Results
- Kalera Public Limited Company (KAL) Income Statement Analysis – Financial Results
- Linedata Services S.A. (LIN.PA) Income Statement Analysis – Financial Results
Ladprao General Hospital Public Company Limited (LPH.BK)
About Ladprao General Hospital Public Company Limited
Ladprao General Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. The company operates Ladprao General Hospital, a private hospital. It provides services in the field of neurology, cardiology, hypertension, dental, hemodialysis, pediatric, refractive surgery, women's health, aesthetics, laser, and dermatology, as well as eye, ear, nose, and throat; and operates health screening, gastrointestinal, liver, bones and joints, physical therapy, and rehabilitation centers. It also offers scientific analytical and diagnostic services for food and agricultural, pharmaceutical, environmental, calibration of instruments, and inspections, as well as certifications in accordance with quality systems and international standards; and hospital management and consulting, health mobile checkups, and nurse services in factories and agencies. In addition, the company researches, develops, cultivates, and distributes herbal products for medical benefits. Ladprao General Hospital Public Company Limited was founded in 1990 and is based in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.23B | 2.42B | 2.50B | 1.80B | 1.58B | 1.53B | 1.43B | 1.33B | 1.24B | 1.13B | 1.06B | 917.43M |
| Cost of Revenue | 1.76B | 1.71B | 1.61B | 1.36B | 1.22B | 1.16B | 1.07B | 982.49M | 935.70M | 815.57M | 732.23M | 651.98M |
| Gross Profit | 473.69M | 709.62M | 891.74M | 441.30M | 357.17M | 368.66M | 360.36M | 345.99M | 308.41M | 312.91M | 330.83M | 265.45M |
| Gross Profit Ratio | 21.21% | 29.36% | 35.66% | 24.50% | 22.59% | 24.17% | 25.24% | 26.04% | 24.79% | 27.73% | 31.12% | 28.93% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 399.18M | 349.23M | 333.61M | 282.60M | 240.37M | 239.14M | 176.27M | 189.66M | 141.57M | 137.48M | 30.04M | 17.18M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 138.79M | 122.06M |
| SG&A | 399.18M | 349.23M | 333.61M | 282.60M | 240.37M | 239.14M | 176.27M | 189.66M | 141.57M | 137.48M | 168.83M | 139.24M |
| Other Expenses | 0.00 | -16.64M | 27.11M | 13.36M | 33.97K | 10.04M | 5.45M | 12.51M | 4.61M | 4.15M | 0.00 | 0.00 |
| Operating Expenses | 399.18M | 332.60M | 333.61M | 282.60M | 240.37M | 239.14M | 217.61M | 189.66M | 167.98M | 168.48M | 168.83M | 139.24M |
| Cost & Expenses | 2.16B | 2.04B | 1.94B | 1.64B | 1.46B | 1.40B | 1.29B | 1.17B | 1.10B | 984.05M | 901.06M | 791.22M |
| Interest Income | 0.00 | 13.05M | 15.37M | 13.10M | 669.45K | 0.00 | 21.83M | 0.00 | 0.00 | 0.00 | 25.20M | 24.15M |
| Interest Expense | 13.45M | 13.05M | 15.37M | 13.10M | 8.68M | 16.83M | 0.00 | 3.01M | 19.59M | 25.54M | 0.00 | 0.00 |
| Depreciation & Amortization | 194.92M | 158.38M | 147.46M | 135.32M | 102.01M | 99.73M | 73.03M | 64.37M | 57.87M | 53.78M | 57.82M | 56.92M |
| EBITDA | 297.85M | 539.02M | 732.71M | 307.39M | 220.36M | 292.42M | 305.44M | 233.20M | 202.92M | 202.36M | 219.82M | 183.13M |
| EBITDA Ratio | 13.34% | 22.42% | 29.30% | 17.07% | 13.93% | 15.59% | 9.94% | 17.55% | 15.94% | 17.56% | 20.68% | 19.96% |
| Operating Income | 102.93M | 380.64M | 585.25M | 172.06M | 116.84M | 139.57M | 148.21M | 168.84M | 125.46M | 123.05M | 162.00M | 126.21M |
| Operating Income Ratio | 4.61% | 15.75% | 23.40% | 9.55% | 7.39% | 9.15% | 10.38% | 12.71% | 10.08% | 10.90% | 15.24% | 13.76% |
| Total Other Income/Expenses | -13.78M | -13.05M | -15.37M | -13.10M | 6.71M | 45.85M | 79.26M | 31.07M | -12.61M | -25.54M | -25.20M | -24.15M |
| Income Before Tax | 89.15M | 367.59M | 569.88M | 158.96M | 123.51M | 185.42M | 227.47M | 187.77M | 125.46M | 123.05M | 136.80M | 102.06M |
| Income Before Tax Ratio | 3.99% | 15.21% | 22.79% | 8.83% | 7.81% | 12.15% | 15.93% | 14.13% | 10.08% | 10.90% | 12.87% | 11.12% |
| Income Tax Expense | 22.64M | 52.93M | 97.33M | 17.50M | 12.64M | 28.36M | 33.49M | 31.65M | 24.90M | 22.16M | 28.37M | 22.59M |
| Net Income | 63.55M | 322.91M | 464.52M | 142.89M | 110.49M | 156.95M | 193.83M | 155.90M | 100.45M | 98.98M | 105.77M | 79.57M |
| Net Income Ratio | 2.85% | 13.36% | 18.57% | 7.93% | 6.99% | 10.29% | 13.58% | 11.74% | 8.07% | 8.77% | 9.95% | 8.67% |
| EPS | 0.09 | 0.45 | 0.65 | 0.20 | 0.15 | 0.21 | 0.26 | 0.21 | 0.17 | 0.18 | 0.19 | 0.29 |
| EPS Diluted | 0.09 | 0.45 | 0.65 | 0.20 | 0.15 | 0.21 | 0.26 | 0.21 | 0.17 | 0.18 | 0.19 | 0.29 |
| Weighted Avg Shares Out | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 733.53M | 750.00M | 750.00M | 588.90M | 550.00M | 550.00M | 275.00M |
| Weighted Avg Shares Out (Dil) | 720.00M | 720.00M | 720.00M | 720.00M | 720.00M | 733.53M | 750.00M | 750.00M | 588.90M | 550.00M | 550.00M | 275.00M |
Source: https://incomestatements.info
Category: Stock Reports